Cardiocast

AHA statement on statin risks, app that diagnoses STEMI, and more


 

This week, the American Heart Association says that statins’ benefits far outweigh the risks, a smartphone app is nearly as good as an ECG at diagnosing STEMI, stroke thrombolysis appears safe in patients prone to GI bleeding, and a new strategy for pausing DOAC therapy works in A-fib patients.

Subscribe to Cardiocast wherever you get your podcasts.
Amazon Alexa
Apple Podcasts

Recommended Reading

Children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes and cardiovascular disease
MDedge Family Medicine
Empagliflozin reduces left ventricular mass
MDedge Family Medicine
‘Phenomenal’ REDUCE-IT establishes triglyceride theory
MDedge Family Medicine
Omega-3 fatty acid supplementation reduces risk of preterm birth
MDedge Family Medicine
Visual representation of atherosclerosis helps reduce cardiovascular risk
MDedge Family Medicine
People with HIV still at increased cardiovascular risk
MDedge Family Medicine
Combined novel risk factors raise coronary event rates
MDedge Family Medicine
Study investigates statin-diabetes link
MDedge Family Medicine
AHA: Statins associated with high degree of safety
MDedge Family Medicine
Obesity meds used by just over half of pediatric obesity programs
MDedge Family Medicine